Skip to main content
. 2021 Sep 9;19(8):741–750. doi: 10.18502/ijrm.v19i8.9622

Table 2.

Discriminated metabolites and their pathways from pathway analysis


Pathway Metabolites Total Hits p-value FDR Impact
Tryptophan metabolism 5-N-Acetylserotonin; Methoxytryptamine; 5-Hydroxyindoleacetate; Melatonin; Indole-3-acetamide; Indole-3-acetate; Anthranilate; 3-Hydroxyanthranilate; Xanthurenic acid 79 9 < 0.001 0.000306 0.22
Tyrosine metabolism L-Tyrosine; 4-Hydroxyphenylpyruvate; Phenol; Formamide; Triiodothyronine; Hydroquinonecarboxylic acid; gentisate; 3,4Dihydroxyphenylpropanoate 76 7 < 0.001 0.00454 0.13
Phenylalanine, tyrosine, and tryptophan biosynthesis 3,4-Dihydroxybenzoic acid; Anthranilic acid; 4-Hydroxyphenylpyruvate; L-Tyrosine 27 4 < 0.001 0.00674 0.08
Phenylalanine metabolism Phenethylamine; Phenylacetic acid; 2-Hydroxyphenylacetate L-Tyrosine 45 4 0.01 0.0320 0.06
Ubiquinone and another terpenoid-quinone biosynthesis 3-(4-Hydroxyphenyl) pyruvate; L-Tyrosine 36 2 0.19 0.0187 0.05
Nitrogen metabolism Anthranilate; L-Tyrosine 39 2 0.21 1.55 0.00
Thiamine metabolism L-Tyrosine 24 1 0.41 0.0878 0.00
Aminoacyl-tRNA biosynthesis L-Tyrosine 75 1 0.81 0.0203 0.00
Porphyrin and chlorophyll metabolism Bilirubin 104 1 0.90 0.0984 0.01
Total: Total number of compounds in the pathway, Hits: Matched number from the user uploaded data, P-value: Original p-value calculated from the enrichment analysis, FDR: P-value adjusted using false discovery rate, Impact: Pathway impact value calculated from pathway topology analysis